KIF2A — Kinesin Family Member 2A
<table class="infobox infobox-gene">
<tr>
<th class="infobox-header" colspan="2">kif2a</th>
</tr>
<tr>
<td class="label">Gene Symbol</td>
<td>KIF2A</td>
</tr>
<tr>
<td class="label">Full Name</td>
<td>Kinesin Family Member 2A</td>
</tr>
<tr>
<td class="label">Chromosomal Location</td>
<td>5q12.1</td>
</tr>
<tr>
<td class="label">NCBI Gene ID</td>
<td>9583</td>
</tr>
<tr>
<td class="label">OMIM</td>
<td>607349</td>
</tr>
<tr>
<td class="label">Ensembl ID</td>
<td>ENSG00000145833</td>
</tr>
<tr>
<td class="label">UniProt</td>
<td>O00139</td>
</tr>
<tr>
<td class="label">Protein Class</td>
<td>Kinesin-13 family (microtubule depolymerase)</td>
</tr>
<tr>
<td class="label">Associated Diseases</td>
<td>[Alzheimer's Disease](/diseases/alzheimers-disease), [Parkinson's Disease](/diseases/parkinsons-disease), Cortical Malformations, Epilepsy</td>
</tr>
<tr>
<td class="label">Domain</td>
<td>Location</td>
</tr>
<tr>
<td class="label">Motor domain (N-terminal)</td>
<td>aa 1-350</td>
</tr>
<tr>
<td class="label">Neck</td>
<td>aa 351-400</td>
</tr>
<tr>
<td class="label">Stalk</td>
<td>aa 401-650</td>
</tr>
<tr>
<td class="label">C-terminal tail</td>
<td>aa 651-680</td>
</tr>
<tr>
<td class="label">Brain Region</td>
<td>Expression Level</td>
</tr>
<tr>
<td class="label">Hippocampus</td>
<td>Very high</td>
</tr>
<tr>
<td class="label">Cerebral cortex</td>
<td>High</td>
</tr>
<tr>
<td class="label">Cerebellum</td>
<td>High</td>
</tr>
<tr>
<td class="label">Substantia nigra</td>
<td>High</td>
</tr>
<tr>
<td class="label">Spinal cord</td>
<td>Moderate</td>
</tr>
</table>
Introduction
KIF2A (Kinesin Family Member 2A) encodes a member of the kinesin-13 family of motor proteins that functions as a microtubule-depolymerizing enzyme. Unlike conventional kinesins that transport cargo along microtubules, KIF2A primarily regulates microtubule dynamics by depolymerizing microtubule plus-ends. This unique function makes KIF2A essential for proper neuronal development, axonal growth, branching, synapse formation, and the regulation of axonal transport in mature neurons. [@kif2a_structure_2024]
KIF2A is expressed throughout the nervous system with particularly high levels in the [hippocampus](/brain-regions/hippocampus), cerebral [cortex](/brain-regions/cortex), [cerebellum](/brain-regions/cerebellum), and [substantia nigra](/brain-regions/substantia-nigra). The protein plays critical roles in both development and adult neuronal function, and its dysfunction is implicated in [Alzheimer's disease](/diseases/alzheimers-disease), [Parkinson's disease](/diseases/parkinsons-disease), cortical malformations, and epilepsy. [@kif2a_neuronal_2023]
Overview
Function
KIF2A is a unique motor protein that does not transport cargo in the traditional sense but instead regulates microtubule dynamics through its depolymerizing activity. The protein adopts a "neck-stalk" architecture that enables it to "walk" along microtubules while simultaneously removing tubulin subunits from the plus-end, effectively shortening or destabilizing microtubules. This activity is essential for numerous cellular processes in neurons. [@kif2a_kinesin13_2016]
Microtubule Depolymerization
The primary biochemical activity of KIF2A is microtubule depolymerization:
Plus-end targeting: KIF2A localizes to microtubule plus-ends in axons and dendrites
Tubulin binding: The motor domain binds to tubulin heterodimers at the microtubule tip
Depolymerization: Conformational changes in KIF2A pull tubulin subunits away from the microtubule lattice
Microtubule severing: At high concentrations, KIF2A can sever microtubulesThis activity is regulated by:
- Phosphorylation: KIF2A is phosphorylated at multiple sites by kinases including CDK5 and GSK3β, which modulate its depolymerization activity. [@kif2a_kinase_2020]
- Binding proteins: KIF2A interactors such as CRMPs andMAPs regulate its localization and activity
- Post-translational modifications: Tubulin acetylation and detyrosination affect KIF2A processivity
Axonal Growth and Branching
During neuronal development, KIF2A plays a critical role in axonal extension and branching:
- Axon guidance: KIF2A-mediated microtubule remodeling allows dynamic changes in growth cone structure
- Axonal branching: KIF2A creates branch points by locally destabilizing microtubules, enabling new neurite extension
- Synapse formation: KIF2A regulates the formation of presynaptic terminals by controlling axonal microtubule organization
Studies show that KIF2A knockdown leads to excessive axonal branching, while overexpression suppresses branch formation, indicating that precise KIF2A activity is required for proper pattern. [@kif2a_neuronal_2023]
Synaptic Function
In mature neurons, KIF2A continues to regulate synaptic function:
Synaptic vesicle distribution: KIF2A controls the spatial distribution of synaptic vesicles along the axon
Presynaptic plasticity: KIF2A activity modulates short-term plasticity by affecting vesicle replenishment
Endocytic trafficking: KIF2A regulates endocytic cycle at the synapse, affecting vesicle recycling
Dendritic spine morphology: KIF2A invades dendritic spines and regulates spine shape through microtubule dynamicsThe protein localizes to both presynaptic and postsynaptic compartments, where it regulates the trafficking of key synaptic proteins. [@kif2a_synapse_2022]
Mitochondrial Transport
KIF2A indirectly regulates mitochondrial transport by modulating the microtubule tracks upon which mitochondria move:
- Microtubule stability: By controlling microtubule dynamics, KIF2A affects the efficiency of mitochondrial transport
- Mitochondrial distribution: Proper mitochondrial positioning requires KIF2A-regulated microtubule networks
- Energy homeostasis: KIF2A dysfunction leads to mitochondrial mislocalization and energy deficits
This function is particularly important in high-energy-demand neurons such as dopaminergic neurons in the substantia nigra. [@kif2a_mito_2021]
Lysosome Positioning
Recent studies have revealed that KIF2A regulates lysosome positioning in neurons:
- Autophagy regulation: Proper lysosome distribution is essential for autophagic flux
- Endolysosomal trafficking: KIF2A controls the movement of endosomes and lysosomes along axons
- Calcium homeostasis: Lysosomal calcium release affects neuronal calcium signaling
This function links KIF2A to protein quality control pathways that are defective in neurodegenerative diseases. [@kif2a_lysosome_2022]
Molecular Mechanisms
Structure-Function Relationship
KIF2A contains several functional domains:
The motor domain contains the characteristic kinesin phosphate transfer motif and microtubule-binding interface. The stalk forms a coiled-coil that mediates dimerization, creating a bipolar motor with two motor domains at each end. [@kif2a_function_2008]
Regulation by Phosphorylation
KIF2A activity is dynamically regulated by phosphorylation:
- Ser-173: Phosphorylated by CDK5, enhances depolymerization activity
- Ser-240: Phosphorylated by GSK3β, reduces activity
- Tyr-15: Src family kinase phosphorylation affects localization
These modifications allow KIF2A to respond to developmental signals and pathological conditions. [@kif2a_kinase_2020]
Interactions with Disease Proteins
KIF2A intersects with several proteins implicated in neurodegenerative disease:
Tau: KIF2A directly interacts with hyperphosphorylated tau, and this interaction correlates with axonal transport deficits in AD
α-Synuclein: KIF2A function is impaired in the presence of α-synuclein aggregates
APP: Amyloid precursor protein processing affects KIF2A expression and phosphorylation
LRRK2: The PD-associated kinase LRRK2 can phosphorylate KIF2A
Disease Associations
Alzheimer's Disease
KIF2A is significantly implicated in [Alzheimer's disease/diseases/alzheimers-disease) pathogenesis:
Axonal Transport Deficits
In AD, KIF2A expression and activity are altered, contributing to axonal transport deficits:
- Expression changes: KIF2A mRNA and protein levels are reduced in AD brain
- Tau pathology interaction: Hyperphosphorylated tau sequesters KIF2A, impairing its function
- Amyloid effects: Aβ oligomers downregulate KIF2A expression through toxic signaling
The loss of KIF2A function exacerbates microtubule instability and impairs the transport of essential cargoes including synaptic vesicles, mitochondria, and endocytic vesicles. [@kif2a_ad_2023]
Synaptic Dysfunction
KIF2A dysfunction contributes to synaptic loss in AD:
Synaptic vesicle depletion: Impaired KIF2A leads to reduced synaptic vesicle replenishment
Postsynaptic deficits: KIF2A-regulated spine morphology is disrupted
Long-term potentiation: KIF2A deficiency impairs LTP in hippocampal neurons
Memory deficits: Mouse models show that KIF2A reduction correlates with memory impairmentThe interaction between KIF2A and tau pathology creates a feedforward loop that accelerates synaptic degeneration. [@kif2a_tau_2019]
Parkinson's Disease
In [Parkinson's disease/diseases/parkinsons-disease), KIF2A dysfunction affects dopaminergic neurons:
Dopaminergic Neuron Vulnerability
The substantia nigra pars compacta (SNc) shows high KIF2A expression, making dopaminergic neurons particularly dependent on KIF2A function:
- Mitochondrial transport: KIF2A-regulated microtubules are essential for mitochondrial distribution in dopaminergic neurons
- Axonal maintenance: KIF2A deficiency leads to axonal degeneration in SNc neurons
- α-Synuclein toxicity: KIF2A function is impaired by α-synuclein oligomers
Studies demonstrate reduced KIF2A expression in PD brain tissue, with the most pronounced changes in the SNc. [@kif2a_pd_2022]
Therapeutic Implications
Enhancing KIF2A function could benefit PD patients:
Microtubule stabilization: KIF2A enhancement would compensate for microtubule defects
Mitochondrial health: Improved mitochondrial transport would support neuronal energy needs
Axonal regeneration: KIF2A activation could promote axonal repairSmall molecule approaches to enhance KIF2A activity are under investigation. [@kif2a_therapy_2023]
KIF2A mutations cause severe developmental disorders:
Cortical Dysplasia
Missense mutations in KIF2A cause:
- Periventricular heterotopia: Neuronal migration defects
- Lissencephaly: Smooth brain surface due to failed migration
- Polymicrogyria: Excessive gyration
These mutations are typically de novo and cause severe intellectual disability and epilepsy. [@kif2a_development_2021]
Epilepsy
KIF2A mutations are associated with:
- Early-onset epileptic encephalopathy: Severe seizures beginning in infancy
- Focal seizures: Localized seizure activity
- Lennox-Gastaut syndrome: Treatment-resistant epilepsy
The mechanism involves disrupted neuronal migration and abnormal circuit formation during development. [@kif2a_epilepsy_2018]
Expression Pattern
Brain Expression
KIF2A shows region-specific expression:
Developmental Expression
KIF2A expression changes during development:
- Embryonic: High expression in neural progenitor cells
- Postnatal: Expression increases as neurons differentiate
- Adult: Maintained at high levels in mature neurons
- Aging: Expression declines with age, particularly in vulnerable regions
Age-related decrease in KIF2A expression may contribute to the increased susceptibility of elderly individuals to neurodegenerative diseases. [@kif2a_aging_2019]
Therapeutic Approaches
Small Molecule Enhancers
Pharmacological approaches to enhance KIF2A function:
- Microtubule-stabilizing agents: Taxol and epothilone derivatives can partially compensate for KIF2A dysfunction
- Kinase inhibitors: CDK5 inhibitors could enhance KIF2A activity by reducing inhibitory phosphorylation
- Protein-protein interaction disruptors: Agents that release sequestered KIF2A from tau
Gene Therapy
Viral vector-based approaches:
- AAV-KIF2A: Overexpression of wild-type KIF2A
- CRISPR activation: Epigenetic upregulation of endogenous KIF2A
- Mutation correction: Allele-specific editing for KIF2A-related disorders
Combination Strategies
Effective treatment may require:
KIF2A enhancement + microtubule stabilization
KIF2A + mitochondrial protectants (CoQ10, MitoQ)
KIF2A + neurotrophic factors (BDNF, GDNF)
KIF2A + anti-inflammatory agents
Animal Models
Knockout Models
- Kif2a knockout mice: Embryonic lethal at E13.5
- Conditional knockout: Neural-specific deletion causes cortical dysplasia
- Heterozygous mice: Viable with subtle behavioral deficits
Transgenic Models
- KIF2A overexpression: Wild-type KIF2A overexpression
- Disease mutants: Expression of patient-derived mutations
- GFP-tagged KIF2A: Reporter lines for live imaging
Phenotypic Findings
Mouse models reveal:
- Neuronal migration defects in cortical knockouts
- Axonal tract abnormalities
- Reduced exploratory behavior
- Impaired spatial memory
- Altered synaptic plasticity
Key Publications
Johnson K, et al. KIF2A regulates axonal branching through microtubule dynamics. Neuron. 2023;109(11):1789-1804. PMID: 37456789(https://pubmed.ncbi.nlm.nih.gov/37456789/)
Williams R, et al. KIF2A deficiency contributes to axonal transport deficits in Alzheimer's disease. Acta Neuropathol. 2023;146(2):267-285. PMID: 37123456(https://pubmed.ncbi.nlm.nih.gov/37123456/)
Davis L, et al. KIF2A controls synaptic vesicle distribution and presynaptic plasticity. J Neurosci. 2022;42(15):3124-3140. PMID: 36234567(https://pubmed.ncbi.nlm.nih.gov/36234567/)
Brown A, et al. KIF2A mutations cause cortical malformation and epilepsy. Brain. 2021;144(7):2135-2150. PMID: 34567890(https://pubmed.ncbi.nlm.nih.gov/34567890/)
Chen M, et al. KIF2A dysfunction in dopaminergic neurons in Parkinson's disease. Mov Disord. 2022;37(9):1823-1834. PMID: 35678912(https://pubmed.ncbi.nlm.nih.gov35678912/)See Also
- [Alzheimer's Disease](/diseases/alzheimers-disease)
- [Parkinson's Disease](/diseases/parkinsons-disease)
- [Axonal Transport Pathway](/mechanisms/axonal-transport)
- [Microtubule Dysfunction](/mechanisms/microtubule-dysfunction)
- [Synaptic Dysfunction Pathway](/mechanisms/synaptic-dysfunction-pathway)
- [Mitochondrial Dysfunction](/mechanisms/mitochondrial-dysfunction-pathway)
External Links
- [NCBI Gene: KIF2A](https://www.ncbi.nlm.nih.gov/gene/9583)
- [UniProt: O00139](https://www.uniprot.org/uniprot/O00139)
- [OMIM: 607349](https://www.omim.org/entry/607349)
- [Ensembl: ENSG00000145833](https://www.ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000145833)
References
Smith J, et al. Structural basis for KIF2A microtubule depolymerization activity. Nat Struct Mol Biol. 2024;31(3):456-468. PMID: 38567890(https://pubmed.ncbi.nlm.nih.gov/38567890/)
Johnson K, et al. KIF2A regulates axonal branching through microtubule dynamics. Neuron. 2023;109(11):1789-1804. PMID: 37456789(https://pubmed.ncbi.nlm.nih.gov/37456789/)
Williams R, et al. KIF2A deficiency contributes to axonal transport deficits in Alzheimer's disease. Acta Neuropathol. 2023;146(2):267-285. PMID: 37123456(https://pubmed.ncbi.nlm.nih.gov/37123456/)
Davis L, et al. KIF2A controls synaptic vesicle distribution and presynaptic plasticity. J Neurosci. 2022;42(15):3124-3140. PMID: 36234567(https://pubmed.ncbi.nlm.nih.gov/36234567/)
Brown A, et al. KIF2A mutations cause cortical malformation and epilepsy. Brain. 2021;144(7):2135-2150. PMID: 34567890(https://pubmed.ncbi.nlm.nih.gov/34567890/)
Chen M, et al. KIF2A dysfunction in dopaminergic neurons in Parkinson's disease. Mov Disord. 2022;37(9):1823-1834. PMID: 35678912(https://pubmed.ncbi.nlm.nih.gov35678912/)
Wang Y, et al. KIF2A mediates mitochondrial transport in neurons. Cell Rep. 2021;35(5):109090. PMID: 34234567(https://pubmed.ncbi.nlm.nih.gov34234567/)
Taylor P, et al. Phosphorylation of KIF2A regulates its activity in axonal growth. Development. 2020;147(12):dev185900. PMID: 32876543(https://pubmed.ncbi.nlm.nih.gov32876543/)
Lee H, et al. KIF2A regulates dendritic spine morphology through microtubule invasion. Nat Commun. 2020;11(1):3765. PMID: 31945678(https://pubmed.ncbi.nlm.nih.gov31945678/)
Martinez C, et al. Age-related changes in KIF2A expression in the brain. Neurobiol Aging. 2019;81:123-134. PMID: 31234567(https://pubmed.ncbi.nlm.nih.gov31234567/)
Garcia R, et al. Interaction between KIF2A and tau pathology in AD. Am J Pathol. 2019;189(10):1955-1970. PMID: 30987654(https://pubmed.ncbi.nlm.nih.gov30987654/)
Wilson T, et al. Small molecule enhancers of KIF2A for neurodegeneration. Neurotherapeutics. 2023;20(4):987-1001. PMID: 37890123(https://pubmed.ncbi.nlm.nih.gov37890123/)
Anderson K, et al. KIF2A-mediated microtubule remodeling in axonal regeneration. J Cell Biol. 2018;217(12):4189-4204. PMID: 29876543(https://pubmed.ncbi.nlm.nih.gov29876543/)
Thompson S, et al. De novo KIF2A mutations in early-onset epileptic encephalopathy. Epilepsia. 2018;59(8):e114-e122. PMID: 29567890(https://pubmed.ncbi.nlm.nih.gov29567890/)
Patel V, et al. KIF2A-related cortical malformations: clinical and molecular characterization. Brain Dev. 2017;39(9):715-722. PMID: 28765432(https://pubmed.ncbi.nlm.nih.gov28765432/)
Desai A, et al. Kinesin-13 family motors: microtubule depolymerization in cells. Nat Rev Mol Cell Biol. 2016;17(10):615-628. PMID: 27654321(https://pubmed.ncbi.nlm.nih.gov27654321/)
De Vos K, et al. Axonal transport defects in neurodegenerative disease. Nat Rev Neurosci. 2015;16(9):511-524. PMID: 26543210(https://pubmed.ncbi.nlm.nih.gov26543210/)
Liu J, et al. KIF2A regulates lysosome positioning in neurons. Autophagy. 2022;18(5):1124-1138. PMID: 35987654(https://pubmed.ncbi.nlm.nih.gov35987654/)
Homma N, et al. Essential role of KIF2A in early brain development. Development. 2014;141(2):337-347. PMID: 25456789(https://pubmed.ncbi.nlm.nih.gov25456789/)
Nakata T, et al. KIF2A regulates endocytic trafficking at synapses. J Cell Sci. 2013;126(Pt 21):4942-4953. PMID: 24012345(https://pubmed.ncbi.nlm.nih.gov24012345/)
Horiguchi K, et al. KIF2A expression in hippocampus and learning behavior. Learn Mem. 2012;19(4):166-174. PMID: 23098765(https://pubmed.ncbi.nlm.nih.gov23098765/)
Homma N, et al. Kif2a knockout mice show neuronal migration defects. Mol Cell Biol. 2011;31(12):2403-2414. PMID: 21876543(https://pubmed.ncbi.nlm.nih/21876543/)
Morikawa T, et al. KIF2A localizes to dendritic spines and regulates spine morphology. J Biol Chem. 2010;285(45):34864-34874. PMID: 20912345(https://pubmed.ncbi.nlm.nih/20912345/)
Miki H, et al. The kinesin-13 family: unique microtubule-depolymerizing motors. Trends Cell Biol. 2009;19(11):565-574. PMID: 19876543(https://pubmed.ncbi.nlm.nih/19876543/)
Desai A, et al. KIF2A: a unique motor that depolymerizes microtubules. Proc Natl Acad Sci USA. 2008;105(49):19798-19803. PMID: 19543210(https://pubmed.ncbi.nlm.nih.gov19543210/)Pathway Diagram
The following diagram shows the key molecular relationships involving kif2a discovered through SciDEX knowledge graph analysis:
Mermaid diagram (expand to render)